Michael Alfieri
Fortune : 13 125 $ au 31/05/2026
Fortune : 13 125 $ au 31/05/2026
Michael Alfieri is Chief Financial & Accounting Officer, Head-Finance at Aldeyra Therapeutics, Inc. since 2024.
Former roles include Controller & Executive Director-Finance at Anika Therapeutics, Inc. from 2010 to 2014, Vice President-Finance at Radius Health, Inc. from 2017 to 2018, VP-Finance, Chief Financial & Accounting Officer at Genocea Biosciences, Inc. from 2018 to 2019, and Controller at Merrimack Pharmaceuticals, Inc. from 2014 to 2017.
Education includes undergraduate and graduate degrees from Bentley University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 13/04/2026 | 7 500 ( 0,01 % ) | 13 125 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ALDEYRA THERAPEUTICS, INC. | Directeur Financier/CFO | 31/08/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
| RADIUS HEALTH, INC. | Corporate Officer/Principal | 01/05/2018 |
| MERRIMACK PHARMACEUTICALS | Comptroller/Controller/Auditor | 01/01/2017 |
| ANIKA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/07/2014 |
| GENOCEA BIOSCIENCES, INC. | Directeur Financier/CFO | 05/03/2019 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
Anika Therapeutics, Inc.
Anika Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair | Health Technology |
Radius Health, Inc.
Radius Health, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes bone health and related therapeutics | Health Technology |
Aldeyra Therapeutics, Inc.
Aldeyra Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for eye diseases | Health Technology |
Genocea Biosciences, Inc.
Genocea Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that discovers and develops novel cancer immunotherapies | Health Technology |
Merrimack Pharmaceuticals, Inc.
Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes drugs for the treatment of immunological & autoimmune diseases and cancer | Health Technology |
Bentley University
Bentley University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national